BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 2838788)

  • 1. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
    Dyall-Smith D; Cory S
    Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylhydrazine stimulates lymphopoiesis and accelerates Abelson murine leukemia virus-induced pre-B cell lymphomas.
    Klinken SP; Holmes KL; Fredrickson TN; Erner SM; Morse HC
    J Immunol; 1987 Nov; 139(9):3091-8. PubMed ID: 2822804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proviral integration of an Abelson-murine leukemia virus deregulates BKLF-expression in the hypermutating pre-B cell line 18-81.
    Kirberg J; Gschwendner C; Dangy JP; Rückerl F; Frommer F; Bachl J
    Mol Immunol; 2005 Jun; 42(10):1235-42. PubMed ID: 15829312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of Abelson murine leukemia virus.
    Witte ON; Rosenberg N; Baltimore D
    Prog Clin Biol Res; 1980; 41():757-64. PubMed ID: 6256775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
    Baum C; Eckert HG; Stocking C; Ostertag W
    Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
    Hines DL
    Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeras between SRS and Moloney murine leukemia viruses reveal novel determinants in disease specificity and MCF recombinant formation.
    Jahid S; Bundy LM; Granger SW; Fan H
    Virology; 2006 Jul; 351(1):7-17. PubMed ID: 16616947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line.
    Rovera G; Valtieri M; Mavilio F; Reddy EP
    Oncogene; 1987 Mar; 1(1):29-35. PubMed ID: 2449644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
    Ch'ang LY; Yang WK; Myer FE; Yang DM
    J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
    Faller DV; Weng H; Choi SY
    Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
    Colledge WH; Gebhardt A; Edge MD; Bell JC
    Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of flat revertant cell lines from A-MuLV-transformed fibroblasts.
    Glass DJ; Rees-Jones RW; Goff SP
    Oncogene Res; 1990; 5(3):175-85. PubMed ID: 2157187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
    Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
    J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.